[1]
M. De Filippo, “Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP)”, Allergol Immunopathol, vol. 50, no. 6, pp. 47–52, Nov. 2022, doi: 10.15586/aei.v50i6.495.